Gene Therapy Market, By Gene Therapy Type (Germline Gene Therapy and Somatic Gene Therapy), By Type of Vector (Viral Vector and Non-viral Vector), By Disease Indication (Cardio Vascular Diseases, Cancer, Genetic Disorders, Neuro Disorders, Infectious Diseases, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI3918 | Publish Date: March 2024 | No. of Pages: 160

Global Gene Therapy Market By Overview

Introduction:

The Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%.

Genes are the composition of an acid which is consists of essential information which is used in the protein production that is necessary for best possible functioning of body. This acid is deoxyribonucleic acid. When proteins are made imperfectly then it is termed as gene mutations, which results into the genetic disorder Gene therapy is projected to introduce healthy gene within the damaged cells that are used to counteract for various abnormal genes. They are also intended to make proteins of interest.

Global Gene Therapy Market By Dynamics

                                                    

Rising demand for gene therapy

Rising demand for gene therapy owing to growing number of patients suffering from cancer, various chronic diseases, hereditary disorders, and HIV is major factor driving growth of the target market, currently. Furthermore, increasing technological developments, innovations, and clinical and pre-clinical trials are some among the major factors expected to propel growth of the gene therapy market over the forecast period.

High Cost

However, high costs associated with treatment of gene therapy, coupled with concerns related to its unethical use are factors expected to limit growth of the target market to some extent in the near future.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Gene Therapy Market By Segmentation

The gene therapy market is segmented on the basis of gene therapy type, type of vector, disease indication, and geography.

On the basis of gene therapy type, the gene therapy market is segmented into germline gene therapy and somatic gene therapy. On the basis of type of vector, the gene therapy has been segmented into viral vector and non-viral vector. On the basis of disease indication the gene therapy market is segmented into cardiovascular disease, cancer, genetic disorders, neuro disorder, infectious disease, and others.

Regional Insights:                                   

On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account major market share as compared to that of other regions, followed by Europe during the forecast year due to growing aging population and stringent regulations in this region are the major factors driving the growth of the gene therapy in North America. The gene therapy is expected to show a significant growth over the forecast period owing to demand from developed markets. Developed markets such as Europe and North America are anticipated to emerge as major growth catalysts over the forecast period.                                              

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Gene Therapy Type- Germline Gene Therapy and Somatic Gene Therapy

By Type of Vector- Viral Vector and Non-viral Vector

By Disease Indication- Cardio Vascular Diseases, Cancer, Genetic Disorders, Neuro Disorders, Infectious Diseases, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the Gene Therapy Market report based on product, mode of delivery and region.

Gene Therapy Market, By Region:

  • North America
    • Middle East & Africa
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • U.S.
    • Canada

Global Gene Therapy Market By Key Players

                                                                                       

Key players operating in the market of gene therapy market includes GlaxoSmithKline plc, Bluebird Bio, Inc., Adaptimmune Therapeutics plc, Celgene Corporation, Shanghai Sunway Biotech Co. Ltd., Merck KGaA, Transgene SA, and OncoGenex Pharmaceuticals, Inc

Global Gene Therapy Market By Company Profile

  • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Bluebird Bio, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Adaptimmune Therapeutics plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Celgene Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Shanghai Sunway Biotech Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Transgene SA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • OncoGenex Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview

Global Gene Therapy Market By Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for Gene Therapy Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Gene Therapy Type
      • Market Snippet, By Type of Vector
      • Market Snippet, By Disease Indication
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Gene Therapy Type,  2020 – 2030, (US$ Mn)
    • Overview             
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Germline Gene Therapy
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Somatic Gene Therapy
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Market Segmentation, By Type of Vector, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Viral Vector
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Non-Viral Vector
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Market Segmentation, By Disease Indication, 2020 – 2030, (US$ Mn)
    • Overview       Cardio Vascular Diseases, Cancer, Genetic Disorders, Neuro Disorders, Infectious Diseases, and Others
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Cardio Vascular Diseases
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cancer
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Genetic Disorder
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Neuro Disorder
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Infectious Diseases
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  1. Global Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Gene Therapy Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type of Vector, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Indication, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Gene Therapy Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type of Vector, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Indication, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Gene Therapy Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type of Vector, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Indication, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Gene Therapy Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type of Vector, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Indication, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Gene Therapy Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type of Vector, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Indication, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  2. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  3. Company Profiles
  • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Bluebird Bio, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Adaptimmune Therapeutics plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Celgene Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Shanghai Sunway Biotech Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • Transgene SA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
  • OncoGenex Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview

The Last Word

    • Future Impact
    • About Us
    • Contact

FAQs

The global gene therapy market is segmented on the basis of gene therapy type, type of vector, disease indication, and geography.

Rising demand for gene therapy owing to growing number of patients suffering from cancer, various chronic diseases, hereditary disorders, and HIV is major factor driving growth of the target market, currently. Furthermore, increasing technological developments, innovations, and clinical and pre-clinical trials are some among the major factors expected to propel growth of the global gene therapy market over the forecast period.

North America is expected to account major market share as compared to that of other regions.

Key players operating in the global market of gene therapy market includes GlaxoSmithKline plc, Bluebird Bio, Inc., Adaptimmune Therapeutics plc, Celgene Corporation, Shanghai Sunway Biotech Co. Ltd., Merck KGaA, Transgene SA, and OncoGenex Pharmaceuticals, Inc.